These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 3487804)

  • 1. Effects of dopaminergic agonists and antagonists on the partially contracted, isolated and perfused renal artery of the rat.
    Rodriguez-Mendez SA; Feria M; Boada J
    Pharmacology; 1986; 32(6):321-5. PubMed ID: 3487804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the responses to some dopamine-receptor agonists and antagonists in the isolated perfused rat kidney.
    Woodman OL; Rechtman MP; Lang WJ
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):203-11. PubMed ID: 6971630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-induced relaxation in isolated intrarenal arteries from adult stroke-prone spontaneously hypertensive rats.
    Gao YJ; Nishimura Y; Suzuki A
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S96-8. PubMed ID: 9072459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the vasodilator action of dopamine and dopamine agonists in the renal and coronary beds of the dog.
    Lang WJ; Woodman OL
    Br J Pharmacol; 1982 Sep; 77(1):23-8. PubMed ID: 6982091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional interaction of dopamine receptors and chronic treatment with dopamine-antagonists].
    Barone P; Tucci I; Parashos SA
    Ann Ist Super Sanita; 1988; 24(4):547-50. PubMed ID: 3265291
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
    Edwards RM
    Eur J Pharmacol; 1986 Jul; 126(1-2):167-70. PubMed ID: 2875883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
    Lewis BM; Dieguez C; Lewis M; Hall R; Scanlon MF
    Endocrinology; 1986 Oct; 119(4):1712-7. PubMed ID: 2428601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilator response to dopamine in the ferret pulmonary circulation.
    Gorman P
    Br J Pharmacol; 1988 May; 94(1):212-8. PubMed ID: 2900036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
    Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE
    Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine.
    Kaiser C; Dandridge PA; Garvey E; Hahn RA; Sarau HM; Setler PE; Bass LS; Clardy J
    J Med Chem; 1982 Jun; 25(6):697-703. PubMed ID: 6980283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH; Bergstrom DA; Weick BG; Walters JR
    Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
    Mittleman G; Rosner AL; Schaub CL
    J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of specific dopaminergic agonists and antagonists in the open-field test.
    Bruhwyler J; Chleide E; Liégeois JF; Delarge J; Mercier M
    Pharmacol Biochem Behav; 1991 Jun; 39(2):367-71. PubMed ID: 1682946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.
    Pfeiffer FR; Wilson JW; Weinstock J; Kuo GY; Chambers PA; Holden KG; Hahn RA; Wardell JR; Tobia AJ; Setler PE; Sarau HM
    J Med Chem; 1982 Apr; 25(4):352-8. PubMed ID: 7069713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prejunctional inhibitory effect of a dopamine D-2 agonist, N-0437, on vascular adrenergic responses.
    Friedman DJ; Budai D; Krause DN; Duckles SP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):853-9. PubMed ID: 2674420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors.
    Cheung TH; Bezzina G; Hampson CL; Body S; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2007 Dec; 195(2):213-22. PubMed ID: 17668188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists.
    Okamura H; Murakami T; Yokoyama C; Nakamura T; Ibata Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1031-7. PubMed ID: 9023320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.